And we're off to NASDAQ...
Press Release Source: Vasogen Inc.
Vasogen Approved for Listing on NASDAQ National Market
Monday December 15, 7:00 am ET
MISSISSAUGA, ON, Dec. 15 /PRNewswire-FirstCall/ - Vasogen Inc. (TSX:VAS - News; AMEX:VSV - News), today announced that it has been approved for listing on the NASDAQ National Market. Trading on the NASDAQ is expected to commence on December 17, 2003, under the symbol VSGN. Vasogen's common shares will continue to trade on the AMEX until that time.
"As we advance our phase III clinical programs in two major areas of cardiovascular disease, listing on the NASDAQ represents a logical next step to support our Company's growth while offering shareholders increased liquidity," said David Elsley, President and CEO of Vasogen. "We have been extremely pleased with the professionalism of the American Stock Exchange, and thank them, as well as our specialist, Performance Capital, for their excellent service and support." |
